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In the recent decades, antibacterial peptides have occupied a strategic position for pharmaceutical drug applications and became
subjectofintenseresearchactivitiessincetheyareusedtostrengthentheimmunesystemofalllivingorganismsbyprotectingthem
frompathogenicbacteria.Thisworkproposesasimpleandeasystatistical/computationalmethodthroughapeptidepolarityindex
measurebywhichanantibacterialpeptidesubgroupcanbeeﬃcientlyidentiﬁed,thatis,characterizedbyahightoxicitytobacterial
membranes but presents a low toxicity to mammal cells. These peptides also have the feature not to adopt to an alpha-helicoidal
structure in aqueous solution. The double-blind test carried out to the whole Antimicrobial Peptide Database (November 2011)
showed an accuracy of 90% applying the polarity index method for the identiﬁcation of such antibacterial peptide groups.
1.Introduction
The increasing resistance of pathogen agents towards mul-
tiple drugs has oriented parts of the investigation in bioin-
formatics to fast and eﬃcient techniques that can predict
the remarkable impact of antibacterial peptide action. These
techniques can help to enhance the sometimes cumbersome
chemical synthetic approach as well as the subsequent trial
and error experiments to identify the peptide performance.
Among the proposed various classiﬁcations of peptides,
one of it refers to the alpha-helicoidal versus beta-sheet
conformation that the peptides can adopt in aqueous solu-
tion. This classiﬁcation refers to the predominance of certain
amino acids in the linear sequence of the peptides such as
proline-arginine, cathelicidin, or cysteine. It is important
to note that such classiﬁcation appears to be without any
inﬂuence on the toxicity or selectivity of the peptide once it
got in contact with the target membrane [1, 2].
Although nature was used as the main source of peptides
with antibacterial properties in the past [3], parts of the
research eﬀorts are now more directed towards synthetic
strategies. One of these synthetic approaches generate the
peptides by replacing and/or removing constitutive amino
acids from a natural peptide known for its antibacterial
action [4], thus trying to reduce its size while keeping or
increasingitstoxicity[5].Anothertechniqueconsistsofjoin-
ingtwopeptidesthatindividuallydonotexhibitantibacterial
properties but combined turn out to be highly toxic [6].
To obtain eﬃcient antibacterial peptides by measuring
the potential action of each altered peptide with the-above2 International Journal of Peptides
described methods would result in a possibility combination
that exceeds by far the capacity of the known veriﬁcation
methods in the laboratory. For instance, the number of pos-
sible peptides to be formed from one peptide with 8 amino
acids in length would be 208 = 25,600,000,000 peptides.
This is the reason why contemporary technique proﬁles to
construct antibacterial peptides are the result of joint com-
putationaland/ormathematicalmethodstosimulatepeptide
variations and then to evaluate and qualify these variations
to eventually determine if the peptide complies with the
required purposes. However, these methods with the aim to
simulate the properties of the peptides as well as to evaluate
their performance respecting all possible combinatorics are
highly complex in their mathematical/computational model
design.
In this paper, we present a statistical method that can
be attributed to a single physical-chemical property, which
is easy to computerize and that eﬃciently identiﬁes antibac-
terial peptide subgroups for its highly selective toxicity
to bacteria, hereinafter referred to as “Selective Cationic
Amphipathic Antibacterial Peptides” (SCAAPs). A SCAAP is
characterizedbybeinglessthan60aminoacidsinlength,not
adopting an alpha-helicoidal structure in neutral aqueous
solution, and showing a therapeutic index higher than 75
[7]. The therapeutic index of a peptide is deﬁned as the ratio
between the minimum inhibitory concentration observed
against mammalian and bacterial cells [7, 8]; that is, the
higher the value, the more speciﬁc the peptide for bacterial-
like membranes. Hence SCAAPs display strong lytic activity
against bacteria but exhibit no toxicity against normal
e u k a r y o t i cc e l l ss u c ha se r y t h r o c y t e s[ 9].
Our method determines an index that we call polarity
index that uses the existent 20 proteic amino acid classiﬁ-
cation diﬀerentiated by its side chain R that divides them
in four types and three categories [10]. The three general
categories of side chains are nonpolar, polar but uncharged,
and charged polar. The nonpolar residues include those with
aliphatic hydrocarbon side chains: Gly, Ala, Val, Leu, Ilu, Pro,
o n ea r o m a t i cg r o u p ,P h e ,a n do n e“ p s e u d o - h y d r o c a r b o n , ”
Met. The polar but neutral category contains two hydroxyl-
containing residues, Ser and Thr; two amides, Asn and Gln;
two with aromatic rings, Tyr and Trp; one with a sulfhydryl
group, Cys. In the charged polar class there are two amino
acids with acidic groups, Asp and Glu, and three bases,
His, Lys, and Arg (Table 1). The polarity index only makes
use of that classiﬁcation to get the SCAAP characteristic
blueprint that in a double-blind test applied to all known
peptides registered in the APD database (November 2011)
[11] showed a very high eﬃciency.
2. Methods
2.1. Physicochemical Properties. Peptides can be expressed
linearly as an amino acid sequence [12]. Such representation
gives the peptide a unique blueprint. From this sequence,
mathematical/computational algorithms have been designed
with diﬀerent complexity levels that measure a variety of
physicochemical properties [13]. Among the properties on
which the linear peptide representation focuses are two that
Table 1: 20 proteinogenic amino acid classiﬁcation diﬀerentiated
by their side chain according to their polarity [10].
Symbol Category 1-letter code
P− polar D, E, Y
N neutral C, G, N, Q, S, T
P+ basic hydrophilic H, K, R
N P n o np o l a rr e s i d u e s A ,F ,I ,L ,M ,P ,V ,W
deﬁne if a peptide falls into the category of SCAAP [7]; that
is, when its measure meets simultaneously the parameters
established for the following physicochemical properties:
(i) isoelectric point [14] (IP) from 9.65 to 11.80,
(ii) hydrophobic moment [14] (HM) from 0.16 to 0.57.
Note that the original parameter values [7]h a v eb e e n
extended. For this work, it was decided to take these two
properties at a maximum range without considering the
so-called AGADIR property, which is the tendency for not
adopting an alpha-helicoidal structure in aqueous solution.
As we have already veriﬁed [13] ,t h i sp r o p e r t yi sn o to f
signiﬁcance for peptides with a length smaller than 22 amino
acids.
A statistical-computational method was designed based
only on one physicochemical property: polarity, which
quickly and eﬃciently discerns if a peptide falls into the
category of SCAAP or not. The veriﬁcation was carried out
by evaluating the IP and HM physicochemical properties.
2.2. Polarity Index Method. The polarity index method uses
the 20 amino acid classiﬁcation diﬀerentiated by their side
chains that fall into four polarity groups: [P+] polar, [N]
neutral, [P+] basic hydrophilic, and [NP] nonpolar residues
(Table 1).
From these four groups, a polarity P[i, j]m a t r i xi sb u i l t
with 16 elements that have as rows and columns the four
diﬀerent polarity groups set in the order P+, P−,N ,N Pa n d
where P[i, j]m a t r i xe l e m e n t s[ i, j] represent the 16 possible
interactions of the groups.
The method consists of the following steps.
(i) Creating a P[i, j] incidence matrix from the subject
peptide.
(ii) Generating a Q[i, j] incidence matrix from the
SCAAP set.
(iii) Comparing the incidences from both P[i, j]a n d
Q[i, j]m a t r i c e s .
2.3. P[i, j] Incidence Matrix from a Subject Peptide. The
P[i, j] incidence matrix is built by adding to each of its
elements the matches that occurred in the peptide subject
sequence from the left to the right with two amino acids
in length and by moving one amino acid to the right at the
time until it arrives at the peptide side end. Each amino acid
pair is related to its polarity group. From that association, we
identify row i and column j. To the P[i, j]m a t r i xe l e m e n tInternational Journal of Peptides 3
Table 2:SCAAPsubjects[7].IP:estimatedisoelectricpoint.HM:hydrophobicmoment.TI:calculatedtherapeuticindex.PeptidesCecropin-
A and CA(1-8)M(1-18)NH2 were used to determine the P[i, j] incidence matrix.
Entry Peptide Sequence IP HM TI
1 (KIAKKIA)2NH2 KIAKKIAKIAKKIA 11.5 0.48 86.2
2 (KLGKKLG)3NH2 KLGKKLGKLGKKLGKLGKKLG 11.7 0.49 98.3
3 Cecropin-A KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK 11.2 0.44 1000.0
4 Melittin GIGAVLKVLTTGLPALISWIKRKRQQ 12.6 0.46 500.0
5 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS 10.8 0.56 75.0
6 CA(1-13)M(1-13)NH2 KWKLFKKIEKVGQGIGAVLKVLTTGL 11.1 0.53 400.0
7 CA(1-8)M(1-18)NH2 KWKLFKKIGIGAVLKVLTTGLPALIS 10.4 0.43 2000.0
Table 3: Number of matches in a typical SCAAP sequence in each peptide database with single or multiple action on fungi, viruses,
mammalian cells, Gram+/Gram− bacteria, cancer cells, insects, parasites, and sperms (see also Section 2.6)[ 7].
Total Action Fungi Viruses Mammalian cells Bacteria Cancer cells Insects Parasites Sperms
879 Unique 0/77 0/22 0/10 51/743 1/16 0/2 0/9 0/0
2644 Multiple 62/638 7/122 20/205 76/1489 21/121 3/20 5/40 1/9
will be added 1, resulting thus in P[i, j] = P[i, j] + 1. Finally,
the P[i, j] incidence matrix relative frequency distribution is
normalized and weighted over a 0.30 factor. This last step
helps to enhance the peptide distinctive characteristics by
increasing the eﬀect of the relative frequency position of the
amino acids pairs in the incidence matrix P[i, j].
2.4. Q[i, j] Incidence Matrix from a SCAAP Set. The
Q[i, j] incidence matrix is determined following the same
procedure as for the P[i, j] incidence matrix. The peptide
used here is the set of peptide sequences described in Table 2.
The peptides used here as SCAAP templates were reported as
SCAAP subjects by Del Rio et al. [7]. From the 7 peptides
submitted, only those with a therapeutic index higher or
equal to 1000 were chosen (Table 2, entries 3 and 7).
2.5. P[i, j] and Q[i, j] Matrices Comparison. In both the
P[i, j] and the Q[i, j] matrices ﬁve stated positions M1,
M2,M 3,M 4,a n dM 16 were identiﬁed, where the subscript
numeral stands for the element position in the matrix. The
ﬁrst row in the matrix represents the ﬁrst four positions,
the second row the next four positions, and so forth until
allocating the last four positions to the last row. The position
of the four elements with higher incidence would be M1,
M2,M 3,a n dM 4 while M16 being the one with the lowest
incidence. If the sequences {M1,M 2,M 3,M 4,M 16.} for both
matrices coincide, the peptide is classiﬁed as SCAAP.
2.6. Trial Data Preparation. 1894 peptides registered in
the Antimicrobial Peptide Database (APD) [11]( N o v e m -
ber 2011) were analyzed and classiﬁed by their single
and multiple action against fungi, virus, mammalian cells,
Gram+/Gram− bacteria, cancer cells, insects, parasites, and
sperms. Peptides with more than one action were not
included. The single action database only includes peptides
with conﬁrmed experimental action on a single pathogen
agent, in contrast to multiple-action databases that contain
peptides with action on two or more pathogen agents. On
this basis, the ﬁgures in multiple action databases are over-
represented.
The veriﬁcation of peptides found in the single-action
database on Gram+/Gram– bacteria was carried out by
validating both the isoelectric point (IP) and hydrophobic
moment (HM) in the ranges stated (see Section 2.1). The
integrity of the APD database information was veriﬁed by
checking identiﬁed peptides by their action in the whole
extent of the database itself.
3. Results
Due to the importance of detecting possible peptide
pathogenic action, the use of computer programs that
evaluate peptic sequences to predict their action on dif-
ferent pathogen agents such as fungi, virus, mammalian
cells, and Gram+/Gram– bacteria has become a standard
practice among diﬀerent research groups. The polarity index
method is one of these computer programs, but it diﬀers
in measuring exclusively one physicochemical property to
identify a SCAAP.
The P[i, j] Incidence matrix delivered by the polarity
index method to identify a SCAAP used two peptides known
by their toxic activity on Gram+/Gram+ bacteria (Table 2,
entries 3 and 7) that turned out to be {M1,M 2,M 3,
M4,M 16} = {16, 4, 13, 15, 10}. SCAAP subjects identiﬁed
from the provided single pathogenic action peptide database
were fungi (0/77), viruses (0/22), mammalian cells (0/10),
Gram+/Gram+ bacteria (51/743), cancer cells (1/16), insects
(0/2), parasites (0/9), and sperms (0/0) (Table 3).
Note that the polarity index method only identiﬁed
SCAAP subjects basically in the bacterial group. Whereas
SCAAP subjects identiﬁed from the multiple pathogenic
action peptide database were fungi (62/638), viruses
(7/122), mammalian cells (20/205), Gram+/Gram+ bacteria
(76/1489), cancer cells (21/121), insects (3/20), parasites
(5/40), and sperms (1/9) (Table 3). Among the 743 peptides
with a single action on Gram+/Gram– bacteria, the polarity
index method identiﬁed 51 SCAAP subjects (Table 4), their4 International Journal of Peptides
Table 4: SCAAP subjects identiﬁed by the polarity index method in APD Gram+/Gram− bacteria database [11] where peptides have action
only on bacteria. IP: estimated isoelectric point. HM: hydrophobic moment. Status: (X) not accepted for its IP and HM parameters, because
the corresponding calculations were out of the ranges [7]( s e eSection 2.1).
No. Peptide Sequence IP HM Status Reference
1 Clavanin D (sea squirt, tunicate,
invertebrates, animals) AFKLLGRIIHHVGNFVYGFSHVF 10.85 0.54 [21]
2 Palustrin-1b (frog, amphibians,
animals; XXU) ALFSILRGLKKLGNMGQAFVNCKIYKKC 10.80 0.49 [22]
3 Palustrin-1d (frog, amphibians,
animals; XXU) ALSILKGLEKLAKMGIALTNCKATKKC 10.50 0.35 [22]
4 Palustrin-1c (frog, amphibians,
animals; XXU) ALSILRGLEKLAKMGIALTNCKATKKC 10.60 0.35 [22]
5 Brevinin-1PRc (frog, amphibians,
animals; XXU) FFPMLAGVAARVVPKVICLITKKC 10.50 0.38 [23]
6 Brevinin-1Be (frog, amphibians,
animals; XXU) FLPAIVGAAAKFLPKIFCVISKKC 10.30 0.43 [24]
7 Brevinin-1HSa (frog, amphibians,
animals; XXU) FLPAVLRVAAKIVPTVFCAISKKC 10.50 0.40 [25]
8 Brevinin-1Ba (frog, amphibians,
animals; XXU) FLPFIAGMAAKFLPKIFCAISKKC 10.30 0.50 [24]
9 Brevinin-1Bc (frog, amphibians,
animals; XXU) FLPFIAGVAAKFLPKIFCAISKKC 10.30 0.49 [24]
10 RANATUERIN 4 (ranatuerin-4, frog,
amphibians, animals; XXU) FLPFIARLAAKVFPSIICSVTKKC 10.50 0.46 [26]
11
Phylloseptin-H11 (PLS-H11,
Phylloseptin-13, PS-13; frog,
amphibians, animals; XXA)
FLSLIPHAINAVGVHAKHF 9.65 0.36 [27]
12
Phylloseptin-H5 (phylloseptin-7,
PLS-H5, PS-7, XXA, frog, amphibians,
animals)
FLSLIPHAINAVSAIAKHF 9.65 0.45 [28]
13
Phylloseptin-H2 (PLS-H2,
Phylloseptin-2, PS-2) (XXA, frog,
amphibians, animals)
FLSLIPHAINAVSTLVHHF 7.80 0.46 X [29]
14 Phylloseptin-B1 (PLS-B1, PBN1; frog,
amphibians, animals; XXA) FLSLIPHIVSGVAALAKHL 9.65 0.46 [30]
15 Papilosin (tunicate, ascidian,
invertebrates, sea animals) GFWKKVGSAAWGGVKAAAKGAAVGGLNALAKHIQ 11.40 0.32 [31]
16
SMAP-34 (sheep myeloid
antimicrobial peptide-34; OaMAP34,
ovine cathelicidin, sheep, ruminant,
animals)
GLFGRLRDSLQRGGQKILEKAERIWCKIKDIFR 10.43 0.48 [32]
17 Caerin 1.17 (frog, amphibians,
animals; XXA) GLFSVLGSVAKHLLPHVAPIIAEKL 9.50 0.49 [33]
18 Caerin 1.18 (frog, amphibians,
animals; XXA) GLFSVLGSVAKHLLPHVVPVIAEKL 9.50 0.50 [33]
19 Fallaxidin 3.2 (XXA, frog, amphibians,
animals) GLLDFAKHVIGIASKL 9.50 0.49 [34]
20 Fallaxidin 3.1 (XXA, frog, amphibians,
animals) GLLDLAKHVIGIASKL 9.50 0.48 [34]
21 Dahlein 5.2 (frog, amphibians,
animals) GLLGSIGNAIGAFIANKLKPK 11.10 0.52 [35]
22 Caerin 1.2 (XXA, frog, amphibians,
animals) GLLGVLGSVAKHVLPHVVPVIAEHL 7.02 0.49 X [36]International Journal of Peptides 5
Table 4: Continued.
No.Peptide Sequence IP HM Status Reference
23 Caerin 1.4 (XXA, frog, amphibians,
animals) GLLSSLSSVAKHVLPHVVPVIAEHL 7.02 0.48 X [36]
24 Palustrin-2SIb (frog, amphibians,
animals; XXU) GLWNSIKIAGKKLFVNVLDKIRCKVAGGCKTSPDVE 10.10 0.36 [37]
25
XPF (the xenopsin precursor
fragment, African clawed frog,
amphibians, animals)
GWASKIGQTLGKIAKVGLKELIQPK 11.00 0.40 [38]
26 Pleurocidin (ﬁsh, animals) GWGSFFKKAAHVGKHVGKAALTHYL 11.00 0.34 [39]
27 Cecropin (insects, invertebrates,
animals) GWLKKIGKKIERVGQNTRDATVKGLEVAQQAANVAATVR 11.30 0.36 [40]
28
Pm mastoparan PMM (insects,
invertebrates, animals; XXA;
derivatives)
INWKKIASIGKEVLKAL 10.80 0.37 [41]
29 Hinnavin II (Hin II, insects,
invertebrates, animals; JJsn) KWKIFKKIEHMGQNIRDGLIKAGPAVQVVGQAATIYKG 10.12 0.45 [42]
30
Ostrich AvBD2 (Ostrich avian beta
defensin 2, ostricacin-1, OSP-1, birds,
animals; BBL)
LFCRKGTCHFGGCPAHLVKVGSCFGFRACCKWPWDV 8.94 0.33 X [43]
31 Clavanin D (sea squirt, tunicate,
invertebrates, animals) LFKLLGKIIHHVGNFVHGFSHVF 10.80 0.56 [44]
32
Enterocin Q (EntQ, class 2d
bacteriocins; leaderless, that is, no
signal peptide, bacteria)
MNFLKNGIAKWMTGAELQAYKKKYGCLPWEKISC 10.00 0.39 [45]
33 Temporin-1Lb (Temporin 1Lb, frog,
amphibians, animals) NFLGTLINLAKKIM 10.80 0.41 [24]
34 Bovine beta-defensin 6 (bBD-6,cow,
ruminant, animals)
QGVRNHVTCRIYGGFCVPIRCPGRTRQIGTCFGRPVKCC-
RRW 11.30 0.37 [46]
35 mBD-4 (mBD4, mouse beta-defensin
4, or Defb4, animals; 3S=S) QIINNPITCMTNGAICWGPCPTAFRQIGNCGHFKVRCCKIR 8.91 0.33 X [47]
36 ChBac5 (Pro-rich; Arg-rich, goat
cathelicidin, ruminant, animals) RFRPPIRRPPIRPPFNPPFRPPVRPPFRPPFRPPFRPPIGPFP 13.45 0.50 [48]
37
Cyclic dodecapeptide (OaDode, ovine
cathelicidin, sheep, ruminant,
animals)
RICRIIFLRVCR 12.00 0.36 [49]
38
Bactenecin (cyclic dodecapeptide,
bovine cathelicidin, cow, cattle,
ruminant, animals; BBMm; JJsn;
derivatives: Bac2A)
RLCRIVVIRVCR 12.00 0.33 [50]
39 RL-37 (RL37, cathelicidin, Old World
monkey, primates, animals) RLGNFFRKVKEKIGGGLKKVGQKIKDFLGNLVPRTAS 11.90 0.59 [51]
40
BACTENECIN 7 (bac-7, bac 7; bac7;
Pro-rich; cow cathelicidin, ruminant,
animals; BBL, SeqAR, BBPP)
RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPI-
PRPLPFPRPGPRPIPRPL 13.20 0.25 [52]
41 Bac4 (Pro-rich, Arg-rich; cow
cathelicidin, ruminant, animals) RRLHPQHQRFPRERPWPKPLSLPLPRPGPRPWPKPL 12.90 0.23 [53]
42 Hyphancin IIIE (insects, invertebrates,
animals) RWKFFKKIERVGQNVRDGLIKAGPAIQVLGAAKAL 11.80 0.41 [54]
43 Cecropin B (insects, invertebrates,
animals) RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAI 11.40 0.42 [55]
44 Hyphancin IIID (insects, invertebrates,
animals) RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKAL 11.80 0.41 [54]
45 Hyphancin IIIG (insects, invertebrates,
animals) RWKVFKKIEKVGRHIRDGVIKAGPAITVVGQATAL 11.80 0.38 [54]6 International Journal of Peptides
Table 4: Continued.
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46 Hyphancin IIIF (insects, invertebrates,
animals) RWKVFKKIEKVGRNIRDGVIKAGPAIAVVGQAKAL 11.80 0.39 [54]
47
Phylloseptin-H4 (Phylloseptin-6,
PLS-H4, PS-6, XXA, frog, amphibians,
animals)
SLIPHAINAVSAIAKHF 9.65 0.47 [29]
48
Pep5 (Lantibiotic, type 1, class 1
bacteriocin, Gram-positive bacteria;
XXT3; XXW3)
TAGPAIRASVKQCQKTLKATRLFTVSCKGKNGCK 11.10 0.27 [56]
49 Clavanin C (sea squirt, tunicate,
invertebrates, animals) VFHLLGKIIHHVGNFVYGFSHVF 9.55 0.47 [21]
50 Andropin (insects, invertebrates,
animals) VFIDILDKVENAIHNAAQVGIGFAKPFEKLINPK 7.50 0.45 X [57]
51
Clavanin A (urochordates, sea squirts,
and sea pork, tunicate, invertebrates,
animals)
VFQFLGKIIHHVGNFVHGFSHVF 9.71 0.61 [21]
IP and HM parameters were calculated and 46 of them are in
the ranges previously mentioned in Section 2.1; that is, IP =
9.65–11.80 and HM = 0.16–0.57.
TheAPDdatabaseinformationintegrityveriﬁcation[11]
showed 14 peptides not classiﬁed yet. When their activity as
SCAAP was double checked by the polarity index method,
therewasamismatch.TheAPDdatabasemarginoferrordid
not exceed 8%.
4. Discussion
All diﬀerent peptide classiﬁcations achieved over the decades
seemtobedirectedtovalidatethepeptideactionandtoxicity.
However, it appears that these two characteristics are intrin-
sically related to the space where the peptide interacts as well
as to the structural form of the subject membrane. Missing
peptide speciﬁcity in the studied isolated peptides indicates
that nature avoids peptide speciﬁcity in order not to favor
certain pathogen agents in their blocking action.
Most peptides found experimentally show multiple
actions on pathogen agents. Thus it appears that the detec-
tion and prediction of antibacterial peptides—in our case
SCAAP—is more related to general, nonspeciﬁc peptide
proﬁlesthat are well known for their antibacterial action. For
that reason and as given in the present case, more eﬃcient
algorithms should rather evaluate fundamental characteris-
tics of such peptides and search for small diﬀerences among
them.
The design of bioinformatical algorithms to detect
antimicrobial peptides is basically of two types.
(i) Based on a system of diﬀerential equations [15] that
characterizes the peptide properties with an expo-
nentially growing complexity.
(ii) The inclusion of multiple peptide characteristics
without aﬀecting its complexity [16] where the
eﬃciency greatly depends on a skillful peptide set
selection.
Our polarity index method falls in the latter category and is
characterized by the following.
(i) Eﬀectively excluding multiple action peptides, with
a margin of error less than 10% and single-action
peptides with a margin of error less than 6%.
(ii) Its eﬃciency to identify SCAAP subjects which is
higher than 90%.
(iii) The simplicity of the computational method which is
easy to implement for massive parallel processing in
GPUs [17].
(iv) Its straightforwardness by measuring the peptide
polarity exclusively and from this information eﬀec-
tively classifying its pathogenic action.
The algorithm involved in this method allows simple modi-
ﬁcations to identify in a general level peptide groups by their
pathogenic action and in a more speciﬁc level to reﬁne the
peptide search and identiﬁcation as in the group used here.
The polarity index method uses the amino acid polarity
classiﬁcation; however there are other types of classiﬁcations
[18, 19] that use the amino acid side chain chemical
properties such as the neutral pH charge, their type of
chemical structure, the reactivity, the elements present, or
the ability to form hydrogen bonds. These classiﬁcations
can be used to generate a more speciﬁc peptide blueprint
when searched, with features that would not be considered
otherwise.
As this method is a simple mathematical and computa-
tional algorithm, it does not demand heavy computational
resources as processing memory or speed; therefore it can
be used to explore peptide regions. These peptide regions
can be worked out by evaluating massively all possible
peptide combinations with the same length [20], thus
taking advantage of the polarity index method simplicity to
determine their activity.International Journal of Peptides 7
5. Conclusion
The statistical/computacional polarity index method is an
eﬀective algorithm to ﬁnd potential antibacterial peptides
from a public domain database. These peptides have been
denominated “Selective Cationic Amphipathic Antibacterial
Peptides” (SCAAP). The method features a high eﬃciency
to exclude peptides that exhibit single pathogenic action on
other pathogens than bacteria, and it is equally eﬃcient to
exclude multiple-action peptides. In summary, the polarity
index method is an adaptable and eﬃcient method to detect
and predict SCAAPs and it is a useful analysis and modeling
tool for biological sequences using a single physicochemical
property.
6.Availability
Thepolarityindexcomputationalimplementationislistedin
the Appendix section.
Appendix
Source Program for the Detection of SCAAP by
the PolarityIndex Method
c Author Carlos Polanco 2011.
c
c Program Detection of SCAAP by Polarity-index
method.
C
c Operating System: GNU Linux Fedora 14
c
c Compilation: gfortran program. f
c
c Execution: ./a.out AEVAPAPAAAAPAKAPKKKA-
AAKPKKAGPS
c
c
implicit none
character ∗ 1 arreglo(100), arreglo3(500)
character ∗ 500 backup
character ∗ 1c o n v e r t
integer convertN, tipo2
integer base(16), candidato(16), aciertos2, acier-
tos0
integer aciertost, aciertos3, aciertos4, aciertos14,
aciertos24
integer aciertos34, aciertos44, aciertos04, acier-
tos1, aciertos5
integer x1, x2, x3, x4, n, j, i, k
real tipo1
real comodin
double precision matriz(4, 4)
double precision total, peso(4, 4)
equivalence (arreglo3, backup)
open (2, ﬁle = “candidate0.dat”)
34 format (f8.4, 1x, I2)
52 format (A3)
c Relative frequency position of pairs of amino acid
in the
c candidate SCAAP
c
peso (4, 4) = 0.272727281/0.272727281
peso (1, 4) = 0.209790215/0.272727281
peso (4, 1) = 0.164335668/0.272727281
peso (1, 1) = 0.087412588/0.272727281
peso (4, 3) = 0.083916083/0.272727281
peso (3, 3) = 0.062937066/0.272727281
peso (3, 4) = 0.059440561/0.272727281
peso (3, 1) = 0.024475524/0.272727281
peso (2, 1) = 0.006993007/0.272727281
peso (1, 3) = 0.006993007/0.272727281
peso (4, 2) = 0.006993007/0.272727281
peso (2,4) = 0.003496503/0.272727281
peso (2, 3) = 0.003496503/0.272727281
peso (1, 2) = 0.003496503/0.272727281
peso (3, 2) = 0.003496503/0.272727281
peso (2, 2) = 0.000000000/0.272727281
c Position of pairs of amino acid in the candidate
SCAAP
c
base(1) = 16
base(2) = 4
base(3) = 13
base(4) = 15
base(5) = 12
base(6) = 1
base(7) = 11
base(8) = 9
base(9) = 3
base(10)= 14
base(11)= 6
base(12)= 8
base(13)= 2
base(14)= 78 International Journal of Peptides
base(15)= 5
base(16)= 10
do i = 1, 4
do j = 1, 4
matriz (i, j) = 0
enddo
enddo
x1 = 0
x2 = 0
x3 = 0
x4 = 0
total = 0
k = 0
n = 0
c Command to gets the peptide (sequence of amino
acid in letter-code)
c
call getarg (1, backup)
do i =1,500
if (arreglo3(i). ne. “ ”) n = n +1
enddo
do i = 1, n
arreglo (i) = convert(arreglo3(i))
enddo
c Procedure to determine the relative frequency
c distribution of amino acid in the sequence
c
do i = 1, (n − 1)
if (arreglo(i).eq. “1”) x1 = x1 + 1
if (arreglo(i).eq. “2”) x2 = x2 + 1
if (arreglo(i).eq. “3”) x3 = x3 + 1
if (arreglo(i).eq. “4”) x4 = x4 + 1
if (arreglo(i).eq. “0”) goto 100
if (arreglo(i).ne. “0”) total = total +1
matriz (convertN (arreglo (i)), convertN
(arreglo (i + 1))) =
& matriz (convertN (arreglo (i)), convertN
(arreglo (i + 1))) + 1
enddo
100 do i = 1, 4
do j = 1, 4
k = k +1
write (2,34) (matriz(i, j) ∗ peso(i, j) ∗
∗1.3)/total, k
enddo
enddo
close(1)
close(2)
call system (“sort −r candidate0.dat > candi-
date1.dat”)
open (3, ﬁle = “candidate1.dat”)
open (4, ﬁle = “candidate0.dat”)
do i = 1, 16
read (3, ∗) tipo1, tipo2
write (4, ∗)t i p o 2
enddo
close(3)
close(4)
open (2, ﬁle = “candidate0.dat”)
c Procedure to evaluate if the sequence of peptide is
or
c not candidate SCAAP
c
do i = 1, 16
read (2, ∗, END = 101) candidato(i)
enddo
call parte04 (base, candidato, aciertos0)
call parte14 (base, candidato, aciertos1)
call parte54 (base, candidato, aciertos5)
if ((aciertos0.eq.1). and.(aciertos1.eq.3).and.
(aciertos5.eq.1))then
write (6, 52) “Yes”
else
write (6, 52) “No”
endif
call system (“rm candidate0.dat”)
call system (“rm candidate1.dat”)
101 stop
end
c
c Subroutines and functions
c
c Veriﬁcation of position 1
c
subroutine parte04(base, candidato, aciertos0)
integer base(16), candidato(16), aciertos0
aciertos0 = 0
if (candidato(1).eq. base(1)) aciertos0 = aciertos0
+1
returnInternational Journal of Peptides 9
end
c Veriﬁcation of positions 2, 3 and 4
c
subroutine parte14(base, candidato, aciertos1)
integer base(16), candidato(16), aciertos1
aciertos1 = 0
do i = 2, 4
if(candidato(i).eq.base(i)) aciertos1=aciertos1+1
enddo
return
end
c Veriﬁcation of position 16
c
subroutine parte54 (base, candidato, aciertos5)
integer base(16), candidato(16), aciertos5
aciertos5 = 0
if (candidato(16).eq. base(16)) aciertos5 = acier-
tos5 + 1
return
end
c Conversion letters to the corresponding groups of
polarity (in numbers)
c
character function convert(tipo)
character ∗ 1t i p o
if (tipo.eq. “A”) convert = “4”
if (tipo.eq. “C”) convert = “3”
if (tipo.eq. “D”) convert = “2”
if (tipo.eq. “E”) convert = “2”
if (tipo.eq. “F”) convert = “4”
if (tipo.eq. “G”) convert = “3”
if (tipo.eq. “H”) convert = “1”
if (tipo.eq. “I”) convert = “4”
if (tipo.eq. “K”) convert = “1”
if (tipo.eq. “L”) convert = “4”
if (tipo.eq. “M”) convert = “4”
if (tipo.eq. “N”) convert = “3”
if (tipo.eq. “P”) convert = “4”
if (tipo.eq. “Q”) convert = “3”
if (tipo.eq. “R”) convert = “1”
if (tipo.eq. “S”) convert = “3”
if (tipo.eq. “T”) convert = “3”
if (tipo.eq. “V”) convert = “4”
if (tipo.eq. “W”) convert = “4”
if (tipo.eq. “Y”) convert = “2”
if (tipo.eq. “X”) convert = “0”
return
end
c Conversion number in code-letters to numbers in
code-numbers
c
integer function convertN(tipo)
character ∗ 1t i p o
if (tipo.eq. “1”) convertN = 1
if (tipo.eq. “2”) convertN = 2
if (tipo.eq. “3”) convertN = 3
if (tipo.eq. “4”) convertN = 4
return
end
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